US Patent Issued to TeneoBio on Sept. 29 for "Multi-specific antibodies binding to BCMA" (California Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,298, issued on Sept. 29, was assigned to TeneoBio Inc. (Thousand Oaks, Calif.).

"Multi-specific antibodies binding to BCMA" was invented by Nathan Trinklein (Newark, Calif.), Katherine Harris (Newark, Calif.), Harbani Malik (Newark, Calif.), Ute Schellenberger (Newark, Calif.), Omid Vafa (Newark, Calif.) and Shelley Force Aldred (Newark, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Multi-specific, human heavy chain antibodies (e.g., UniAbsm) binding to BCMA are disclosed, along with methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and their use to treat disorders that are c...